Polyclonal Rabbit anti‑Human GDF2 / BMP9 Antibody (aa413‑425, IHC, WB) LS‑C405892
Polyclonal Rabbit anti‑Human GDF2 / BMP9 Antibody (aa413‑425, IHC, WB) LS‑C405892
Antibody:
GDF2 / BMP9 Rabbit anti-Human Polyclonal (aa413-425) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
GDF2 / BMP9 Rabbit anti-Human Polyclonal (aa413-425) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
BMP9 antibody LS-C405892 is an unconjugated rabbit polyclonal antibody to BMP9 (GDF2) (aa413-425) from human. It is reactive with human and mouse. Validated for ELISA, IHC and WB.
Target
Human GDF2 / BMP9
Synonyms
GDF2 | BMP-9 | BMP9 | GDF-2 | Bone morphogenetic protein 9
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Affinity purification
Immunogen
Synthetic peptide of human GDF2
Specificity
Human GDF2 / BMP9
Applications
- IHC (1:40)
- Western blot (1:200 - 1:1000)
- ELISA
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.4, 0.05% Sodium Azide, 50% Glycerol
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, ELISA, Functional Assay, Neutralization
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Reactivity:
Human
Range:
1.56-100 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/22/2024